theophylline has been researched along with Lung Diseases, Interstitial in 1 studies
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodwin, AT | 1 |
| Singanayagam, A | 1 |
| Jenkins, G | 1 |
1 other study available for theophylline and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Review of the British Thoracic Society Winter Meeting 2018, 5-7 December 2018, London, UK.
Topics: Asthma; Bronchodilator Agents; Cystic Fibrosis; Drug Resistance, Microbial; Genetic Therapy; Humans; | 2019 |